Ingelheim: A look at the city's economic strength!

Ingelheim am Rhein, a middle city in Rhineland-Palatinate, is enjoying high tax revenue due to its economic strength. One of the main reasons for this is the settlement of important companies, above all the largest pharmaceutical company in Germany, Boehringer Ingelheim , which has its roots in the city. Founded in 1885 by Albert Boehringer, the company now employed over 53,000 people and generated sales of 25.6 billion euros in 2023. This takes Ingelheim to the richest cities in Germany with a population of 36,390 (late 2023).

Mayor Ralf Claus (SPD) emphasizes the positive financial aspects of the city. The high commercial revenue enables discounts for citizens, such as reduced admission prices for the municipal swimming pool. In addition, the per capita debt in Ingelheim is low compared to other cities. Despite the current economic crisis, Boehringer Ingelheim shows a positive development and looks optimistically into the future. The headquarters in Ingelheim also benefits from the company's largest research and development location in Biberach an der Riß.

economic developments

The economic strength of Ingelheim can also be seen in the large number of other resident companies, such as C. H. Boehringen's son, Weber Inc. and Pax AG. The city benefits not only from the high tax revenue, but also from the innovative strength and the growth of companies on site. Boehringer Ingelheim itself has continuously adapted its presence and structures to meet the challenges of the market.

An overview of the company structure of Boehringer Ingelheim shows the company's comprehensive organization. Among other things, changes were noted in the commercial register that affect the procuration, management and social contracts. This also includes the domination and result transfer agreement with the C.H. Boehringer Sohn AG & Co. KG, which was completed on October 22, 2004 and was adapted several times, such as Online-handels register